26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

erythroblastosis fetalis 255 estrogen/progesterone receptor protein<br />

Erythema multiforme. Immunocytes in dermis.<br />

Neutrophils, macrophages, and lymphocytes infiltrate the<br />

subcutaneous fat.<br />

erythroblastosis fetalis<br />

A human fetal disease induced by immunoglobulin G (IgG)<br />

antibodies passed across the placenta from mother to fetus<br />

that are specific for fetal red blood cells, leading to their<br />

destruction. Although not often a serious problem until<br />

the third pregnancy, the escape of fetal red blood cells into<br />

the maternal circulation, especially at the time of parturition,<br />

produces a booster response in the mother of the IgG<br />

antibody that produces an even more severe reaction in<br />

the second and third fetus. The basis for this reaction is an<br />

isoantigen such as RhD antigen not present in the mother<br />

but present in the fetal red cells and inherited from the<br />

father. Clinical consequences of this maternal–fetal blood<br />

group incompatibility include anemia, jaundice, kernicterus,<br />

hydrops fetalis, and even stillbirth. Preventive therapy<br />

now includes administration of anti-D antiserum (RhIG)<br />

within 72 hours following parturition. This antibody combines<br />

with the fetal red cells dumped into the mother’s circulation<br />

at parturition and dampens production of a booster<br />

response. This is an antibody-mediated type II hypersensitivity<br />

reaction. May also be called Rh disease.<br />

erythrocyte<br />

Red blood cell.<br />

erythrocyte agglutination test<br />

Refer to hemagglutination test.<br />

erythrocyte autoantibodies<br />

Autoantibodies against erythrocytes. They are of significance<br />

in the autoimmune form of hemolytic anemia and<br />

are usually classified into cold and warm varieties by the<br />

thermal range of their activity.<br />

erythroid progenitor<br />

An immature cell that leads to the production of erythrocytes<br />

and megakaryocytes, but no other blood cell types.<br />

erythropoiesis<br />

The formation of erythrocytes or red blood cells.<br />

erythropoietin<br />

A 46-kDa glycoprotein produced by the kidney, more<br />

specifically by cells adjacent to the proximal renal tubules,<br />

based on the presence of oxygen-sensitive substances such<br />

as heme in the kidneys. It stimulates red blood cell production<br />

by combining with erythroid precursor receptors to<br />

promote mature red cell development. Erythropoietin formation<br />

is increased by hypoxia. It is useful in the treatment<br />

of various types of anemia.<br />

Escherichia coli immunity<br />

Immunoglobulin M (IgM) and IgG antibodies are formed<br />

against O, H, and K antigens of E. coli of the diarrhea-producing<br />

strains in infants. Secretory IgA specific for E. coli<br />

diminishes the adherence of diarrhea-producing E. coli<br />

in the intestines of infants. Secretory IgA in breast milk<br />

also offers significant protection of infants through passive<br />

immunity. Secretory IgA may be specific for LT enterotoxins<br />

and for colonization factor antigens.<br />

essential mixed cryoglobulinemia<br />

A condition that is identified by purpura (skin hemorrhages),<br />

joint pains, impaired circulation in the extremities<br />

on exposure to cold (Raynaud’s phenomenon), and glomerulonephritis.<br />

Renal failure may result. Polyclonal immunoglobulin<br />

G (IgG), IgM, and complement are detectable as<br />

granular deposits in the glomerular basement membranes.<br />

The cryoprecipitates containing IgG and IgM may also<br />

contain hepatitis B antigen, as this condition is frequently a<br />

sequela of hepatitis B.<br />

estradiol<br />

In diagnostic immunology, a marker identifiable in<br />

breast carcinoma tissue by monoclonal antibody and the<br />

immunoperoxidase technique that correlates, to a limited<br />

degree, with estrogen receptor activity in cytosols from the<br />

same preparation.<br />

Estrogen receptor⎯carcinoma of the breast.<br />

estrogen/progesterone receptor protein<br />

Monoclonal antibodies against estrogen receptor protein<br />

and progesterone receptor protein permit identification of<br />

tumor cells by their preferential immunoperoxidase staining<br />

E

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!